The Emirates Drug Establishment (EDE) has signed a memorandum of understanding (MoU) with Novo Nordisk, the global healthcare company known for its treatments for diabetes, obesity and rare diseases, to strengthen cooperation in pharmaceutical manufacturing through advanced technologies.
